INNV vs. TALK, WGS, DCGO, PNTG, SHCR, PIII, LFMD, CDMO, PETQ, and CELC
Should you be buying InnovAge stock or one of its competitors? The main competitors of InnovAge include Talkspace (TALK), GeneDx (WGS), DocGo (DCGO), The Pennant Group (PNTG), Sharecare (SHCR), P3 Health Partners (PIII), LifeMD (LFMD), Avid Bioservices (CDMO), PetIQ (PETQ), and Celcuity (CELC). These companies are all part of the "medical" sector.
InnovAge (NASDAQ:INNV) and Talkspace (NASDAQ:TALK) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment, risk and community ranking.
In the previous week, InnovAge had 1 more articles in the media than Talkspace. MarketBeat recorded 6 mentions for InnovAge and 5 mentions for Talkspace. Talkspace's average media sentiment score of 0.34 beat InnovAge's score of 0.09 indicating that Talkspace is being referred to more favorably in the news media.
InnovAge presently has a consensus price target of $6.50, suggesting a potential upside of 59.31%. Talkspace has a consensus price target of $3.00, suggesting a potential downside of 4.15%. Given InnovAge's higher possible upside, equities research analysts plainly believe InnovAge is more favorable than Talkspace.
12.3% of InnovAge shares are held by institutional investors. Comparatively, 57.4% of Talkspace shares are held by institutional investors. 0.4% of InnovAge shares are held by insiders. Comparatively, 18.4% of Talkspace shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
InnovAge and Talkspace both received 0 outperform votes by MarketBeat users.
Talkspace has lower revenue, but higher earnings than InnovAge. Talkspace is trading at a lower price-to-earnings ratio than InnovAge, indicating that it is currently the more affordable of the two stocks.
InnovAge has a beta of 0.24, indicating that its stock price is 76% less volatile than the S&P 500. Comparatively, Talkspace has a beta of 1.29, indicating that its stock price is 29% more volatile than the S&P 500.
InnovAge has a net margin of -4.38% compared to Talkspace's net margin of -12.78%. InnovAge's return on equity of -10.53% beat Talkspace's return on equity.
Summary
InnovAge and Talkspace tied by winning 7 of the 14 factors compared between the two stocks.
Get InnovAge News Delivered to You Automatically
Sign up to receive the latest news and ratings for INNV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding INNV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
InnovAge Competitors List
Related Companies and Tools
